Resmed Inc (RMD) Return on Equity ROE from the fourth quarter 2026 to fourth quarter 2025 and annually, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Resmed Inc   (NYSE: RMD)

Resmed Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Resmed Inc in the fourth quarter 2026?
Resmed Inc achieved a return on average equity (ROE) of 24.21 % in its fourth quarter 2026, this is above RMD's average return on equity of 20.57%.
Resmed Inc s equity during the 12 months ending in the fourth quarter 2026 are valued at $6 billion

ROE decreased relative to the period ending , due to the decline in net income.

Within the Medical Equipment & Supplies industry 11 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the third quarter 2026 from 475 to 519.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2026)
IV. Quarter		 (Mar 31 2026)
III. Quarter		 (Dec 31 2025)
II. Quarter		 (Sep 30 2025)
I. Quarter		 (Jun 30 2025)
IV. Quarter
Y / Y Equity Change 10.35 % 17.05 % 22.69 % 17.83 % -
Y / Y Net Income Change 0.98 % 9.23 % 13.92 % 11.94 % 29.93 %
Net Income (TTM) in Millions 1,523 1,520 1,486 1,438 1,401
Return On Equity (TTM) 24.21 % 24.76 % 25.18 % 25.56 % 25.97 %
RMD's Total Ranking # 519 # 475 # 352 # 405 # 386
Equity (TTM) in Millions 6,585 6,492 5,968 6,121 5,968
Seq. Equity Change 1.44 % 8.78 % -2.51 % 2.57 % 7.6 %
Seq. Net Income Change -3.84 % 1.56 % 12.64 % -8.21 % 4.02 %

Back to RMD Management Effectiveness >> RMD's 5 Years Annual ROE >> Compare RMD ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 12
Sector # 69
Overall # 519

Return On Equity Statistics
High Average Low
28.61 %
20.57 %
8.21 %
(Sep 30 2020)   (Jun 30 2013)





RMD Annual Return On Equity (Jun 30 2026)
2026		 (Jun 30 2025)
2025		 (Jun 30 2024)
2024		 (Jun 30 2023)
2023		 (Jun 30 2022)
2022
Total Equity in Millions 6,585 5,968 4,864 4,130 3,361
Y / Y Equity Change 10.35 % 22.69 % 17.78 % 22.89 % 16.46 %
Net Income in Millions 1,523 1,401 1,021 898 779
Y / Y Net Income Change 8.75 % 37.2 % 13.75 % 15.15 % 64.26 %
Return On Equity 23.13 % 23.47 % 20.99 % 21.73 % 23.19 %

Back to RMD Management Effectiveness >> RMD's 5 Years Annual ROE >> Compare RMD ROE to its Competitors




Annual Roe Comment
In 2026 ROE fell to 23.13 %, despite net income growth.


More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
RMD's' Return on Equity at Yahoo Finance
RMD's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for RMD's Competitors
Subscribers only: Roe for Resmed Inc 's Suppliers
Subscribers only: Return On Equity for RMD's Customers




Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector ROE
Earth Science Tech Inc   66.17 %
Aurinia Pharmaceuticals Inc   59.00 %
Vaxart Inc   53.04 %
Qhslab Inc   51.21 %
Tenet Healthcare Corp  50.64 %
Nrc Health  48.29 %
Concentra Group Holdings Parent Inc   48.13 %
Bristol myers Squibb Company  46.65 %
Agilent Technologies inc   41.99 %
Eton Pharmaceuticals Inc   40.13 %
Adma Biologics Inc   39.59 %
Dexcom Inc   36.25 %
Transmedics Group Inc   33.37 %
Arcutis Biotherapeutics Inc   32.92 %
Caredx Inc   32.81 %
Zevra Therapeutics Inc   32.56 %
Acadia Pharmaceuticals Inc   32.39 %
Pro dex Inc   31.96 %
Protalix Biotherapeutics inc   31.61 %
Illumina Inc   31.08 %
Innoviva Inc   30.03 %
Phibro Animal Health Corporation  29.66 %
Chemed Corporation  29.45 %
Solventum Corporation  28.96 %
Pacs Group Inc   27.00 %
Sotera Health Company  26.75 %
Insulet Corporation  26.69 %
Bioventus Inc   25.96 %
Johnson and Johnson  25.74 %
Encompass Health Corporation  25.52 %

Date modified: 2026-09-08T15:22:21+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.